Advertisement for orthosearch.org.uk
Results 1 - 35 of 35
Results per page:
The Bone & Joint Journal
Vol. 105-B, Issue 8 | Pages 837 - 838
1 Aug 2023
Kelly M McNally SA Dhesi JK


Bone & Joint Research
Vol. 11, Issue 1 | Pages 29 - 31
20 Jan 2022
Ma M Tan Z Li W Zhang H Liu Y Yue C


Bone & Joint Research
Vol. 10, Issue 9 | Pages 571 - 573
2 Sep 2021
Beverly MC Murray DW


Bone & Joint Open
Vol. 5, Issue 9 | Pages 766 - 767
13 Sep 2024
Parker MJ


The Bone & Joint Journal
Vol. 106-B, Issue 2 | Pages 111 - 113
1 Feb 2024
Howard A Thomas GER Perry DC


Bone & Joint 360
Vol. 13, Issue 2 | Pages 5 - 6
1 Apr 2024
Ollivere B


The Bone & Joint Journal
Vol. 105-B, Issue 6 | Pages 590 - 592
1 Jun 2023
Manktelow ARJ Mitchell P Haddad FS

Cite this article: Bone Joint J 2023;105-B(6):590–592.


The Bone & Joint Journal
Vol. 104-B, Issue 12 | Pages 1281 - 1283
1 Dec 2022
Azizpour K Birch NC Peul WC


Bone & Joint 360
Vol. 12, Issue 2 | Pages 3 - 4
1 Apr 2023
Rocos B Ruffles K


Bone & Joint Research
Vol. 12, Issue 1 | Pages 5 - 8
1 Jan 2023
Im G

Cite this article: Bone Joint Res 2023;12(1):5–8.


Bone & Joint Research
Vol. 11, Issue 1 | Pages 26 - 28
20 Jan 2022
Ma M Tan Z Li W Zhang H Liu Y Yue C


The Bone & Joint Journal
Vol. 104-B, Issue 3 | Pages 309 - 310
1 Mar 2022
Haddad FS


The Bone & Joint Journal
Vol. 103-B, Issue 11 | Pages 1642 - 1645
1 Nov 2021
Kayani B Giebaly D Haddad FS


The Bone & Joint Journal
Vol. 103-B, Issue 10 | Pages 1553 - 1554
1 Oct 2021
Haddad FS


Bone & Joint Research
Vol. 10, Issue 6 | Pages 348 - 350
1 Jun 2021
Skinner JA Sabah SA Hart AJ


The Bone & Joint Journal
Vol. 103-B, Issue 5 | Pages 805 - 806
1 May 2021
Magan AA Haddad FS



The Bone & Joint Journal
Vol. 103-B, Issue 4 | Pages 597 - 599
1 Apr 2021
Kader DF Oussedik S Kader N Haddad FS


Bone & Joint Research
Vol. 10, Issue 2 | Pages 134 - 136
1 Feb 2021
Im G

The high prevalence of osteoarthritis (OA), as well as the current lack of disease-modifying drugs for OA, has provided a rationale for regenerative medicine as a possible treatment modality for OA treatment. In this editorial, the current status of regenerative medicine in OA including stem cells, exosomes, and genes is summarized along with the author’s perspectives. Despite a tremendous interest, so far there is very little evidence proving the efficacy of this modality for clinical application. As symptomatic relief is not sufficient to justify the high cost associated with regenerative medicine, definitive structural improvement that would last for years or decades and obviate or delay the need for joint arthroplasty is essential for regenerative medicine to retain a place among OA treatment methods.

Cite this article: Bone Joint Res 2021;10(2):134–136.


Bone & Joint Research
Vol. 9, Issue 4 | Pages 200 - 201
1 Apr 2020
Simpson AHRW Dall G Haas JG


The Bone & Joint Journal
Vol. 101-B, Issue 12 | Pages 1469 - 1471
1 Dec 2019
Haddad FS Horriat S


The Bone & Joint Journal
Vol. 101-B, Issue 9 | Pages 1033 - 1034
1 Sep 2019
Rodeo S Haddad FS


Bone & Joint Research
Vol. 7, Issue 12 | Pages 636 - 638
1 Dec 2018
Roussot MA Haddad FS


The Bone & Joint Journal
Vol. 100-B, Issue 1 | Pages 1 - 3
1 Jan 2018
Skinner JA Haddad FS


Bone & Joint Research
Vol. 6, Issue 12 | Pages 665 - 666
1 Dec 2017
Hamilton DF Giesinger JM Giesinger K


The Bone & Joint Journal
Vol. 99-B, Issue 9 | Pages 1123 - 1124
1 Sep 2017
Parsons NR Perry DC Costa ML


The Bone & Joint Journal
Vol. 99-B, Issue 4_Supple_B | Pages 1 - 2
1 Apr 2017
Manktelow ARJ Gehrke T Haddad FS


The Bone & Joint Journal
Vol. 99-B, Issue 3 | Pages 291 - 294
1 Mar 2017
Javaid MK Handley R Costa ML


Bone & Joint Research
Vol. 5, Issue 3 | Pages 92 - 94
1 Mar 2016
Murray IR LaPrade RF


The Bone & Joint Journal
Vol. 98-B, Issue 8 | Pages 1009 - 1010
1 Aug 2016
Haddad FS


Bone & Joint Research
Vol. 4, Issue 12 | Pages 195 - 197
1 Dec 2015
Simpson AHRW Dave J Ghert M


Bone & Joint 360
Vol. 4, Issue 2 | Pages 1 - 1
1 Apr 2015
Ollivere B


The Bone & Joint Journal
Vol. 96-B, Issue 12 | Pages 1575 - 1577
1 Dec 2014
Perry DC Parsons N Costa ML

The extent and depth of routine health care data are growing at an ever-increasing rate, forming huge repositories of information. These repositories can answer a vast array of questions. However, an understanding of the purpose of the dataset used and the quality of the data collected are paramount to determine the reliability of the result obtained.

This Editorial describes the importance of adherence to sound methodological principles in the reporting and publication of research using ‘big’ data, with a suggested reporting framework for future Bone & Joint Journal submissions.

Cite this article: Bone Joint J 2014;96-B:1575–7.


The Bone & Joint Journal
Vol. 96-B, Issue 7 | Pages 853 - 854
1 Jul 2014
Parsons N Griffin XL Stengel D Carey Smith R Perry DC Costa ML

The Bone & Joint Journal provides the latest evidence to guide the clinical practice of orthopaedic surgeons. The benefits of one intervention compared with another are presented using outcome measures; some may be specific to a limb or joint and some are more general health-related quality of life measures. Readers will be familiar with many of these outcome measures and will be able to judge the relative benefits of different interventions when measured using the same outcome tool; for example, different treatments for pain in the knee measured using a particular knee score. But, how should readers compare outcomes between different clinical areas using different outcome measures? This article explores the use of standardised effect sizes.

Cite this article: Bone Joint J 2014;96-B:853–4.


The Bone & Joint Journal
Vol. 95-B, Issue 8 | Pages 1009 - 1010
1 Aug 2013
Haddad FS